Diagnostic Accuracy of Notified Cases as Pulmonary Tuberculosis in Private Sectors of Korea by Jeong, Ina et al.
© 2012 The Korean Academy of Medical Sciences.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) 
which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
pISSN 1011-8934
eISSN 1598-6357
Diagnostic Accuracy of Notified Cases as Pulmonary Tuberculosis 
in Private Sectors of Korea 
The diagnostic accuracy of the data reported in the Korean tuberculosis surveillance system 
(KTBS) has not been adequately investigated. We reviewed the clinical data of pulmonary 
tuberculosis (PTB) cases notified from private medical facilities through KTBS between 
January and June, 2004. PTB cases were classified into definite (culture-proven), probable 
(based on smear, polymerase chain reaction, histology, bronchoscopic finding, computed 
tomography, or both chest radiograph and symptoms) or possible (based only on chest 
radiograph) tuberculosis. Of the 1126 PTB cases, sputum AFB smear and culture were 
requested in 79% and 51% of the cases, respectively. Positive results of sputum smear and 
culture were obtained in 43% and 29% of all the patients, respectively. A total of 73.2% 
of the notified PTB cases could be classified as definite or probable and 81.7% as definite, 
probable, or possible. However, where infection was not confirmed bacteriologically or 
histologically, only 60.1% of the patients were definite, probable, or possible cases. More 
than 70% of PTB notified from private sectors in Korea can be regarded as real TB. The 
results may also suggest the possibility of over-estimation of TB burden in the use of the 
notification-based TB data.
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INTRODUCTION
Tuberculosis (TB) still remains a huge health burden worldwide. 
The World Health Organization (WHO) estimated that 9.3 mil-
lion new cases and 1.7 million deaths by TB occurred in 2007 
globally, based on data provided by individual countries includ-
ing Korea (1, 2). Korea has evaluated the burden of TB using 
several methods. From 1965 to 1995, the Korean National Tuber-
culosis Association conducted seven nationwide TB prevalence 
surveys at five-year intervals (3, 4) which provided useful infor-
mation identifying the status and trends of TB in Korea. How-
ever, the nationwide surveys had limitations: for example, as TB 
prevalence rate decreased, the sample size required for a survey 
increased, which led to a higher cost. Thus, a web-based sur-
veillance system named as the Korean TB surveillance system 
(KTBS) based on notification launched in 2000 and has been 
implemented across the country in place of additional nation-
wide surveys (5). 
  By Korean TB Prevention Law, physicians in both public and 
private sector making or suspecting the diagnosis of TB are legal-
ly responsible for notification, and these notified data are col-
lected in KTBS. The Korean government reported the incidence 
rate based on the KTBS data. As a result, the number of TB cases 
reported from the private sector were included in the national 
figure for the first time (6). Although KTBS is a simple way to col-
lect and analyze massive data on the TB burden in Korea, eval-
uating the accuracy of data from KTB S is essential (7). However, 
there have been concerns on the completeness and the accuracy 
of the data especially from private sectors. First, there are possi-
bilities of missed notifications, which can result in an underes-
timation of TB burden (7-13). On the contrary, a question whether 
a ‘notified TB’ case is a ‘real TB’ can also be raised. Some noti-
fied cases as TB might not be real TB cases, which can lead to 
overestimating the TB burden. In fact, a study reported that the 
concordance rate between notified TB reports and medical re-
cords of ‘sputum culture examination’ was lower than expected 
(23%) in one private general hospital in Korea (14). However, 
there have been no comprehensive analyses on the diagnostic 
accuracy of the notified cases as pulmonary tuberculosis (PTB) 
of private sectors in Korea. 
  The aim of our study was to estimate the diagnostic accuracy 
in pulmonary TB patients notified from private sectors of Korea 
by analyzing the randomly sampled notified cases with a sensi-
tive analysis. 
 
MATERIALS AND METHODS
Case definitions for surveillance and notification
For disease surveillance, the diagnosis of TB was standardized 
on the basis of laboratory and/or clinical evidence of active dis-Jeong I, et al.  •  Diagnostic Accuracy of Notified Pulmonary Tuberculosis
526   http://jkms.org http://dx.doi.org/10.3346/jkms.2012.27.5.525
ease due to the Mycobacterium tuberculosis complex. The WHO/ 
IUATLD case definitions were used in both the public and pri-
vate sectors. A definite tuberculosis case is culture positive case 
for M. tuberculosis complex (15). Notification was conducted by 
the standard nationwide surveillance systems (KTBS) which 
was supervised by the Korea Centers for Disease Control and 
Prevention. The TB notification form included case character-
istics, history of previous treatment, history of BCG vaccination, 
examinations for diagnosis (such as sputum smear or culture, 
histologic and radiological examinations, tuberculin skin test), 
site of tuberculosis by International Classification of Disease-10 
(ICD-10) code and treatment information (16).
Data collection and Study population selection
A total of 20,652 patients were reported as ‘new’ TB cases from 
private sectors of Korea in 2004. Among the 10,160 notified new 
tuberculosis cases during the first half of 2004, 1,530 cases from 
488 private medical facilities were randomly selected by strati-
fied proportional to size sampling by region and classification 
(general hospital, hospital, clinic). After the selection, medical 
records of TB patients treated at private sector during that peri-
od were collected by requesting the selected medical facilities 
to send copies of medical records and to complete a question-
naire between December 2005 and January 2006. The question-
naire included demographics, types of TB by site, history of treat-
ment, ICD-10 code, results of initial and follow up chest radio-
graphs, results of sputum smear and culture examinations for 
diagnosis, the date of diagnosis or treatment, and the initial treat-
ment regimen. After collecting requested medical records and 
additional questionnaire from each relevant private sector, re-
inforcement work has been performed by health workers in the 
public health centers or co-workers of this study. All of the col-
lected data were transferred to and organized at the Korea Insti-
tute of Tuberculosis (KIT). The cases that were notified as PTB 
were included in the study. Of the 1,530 randomly selected pa-
tients, the cases without the ICD-10 code at notification (cases 
lacking clinical information or cases other than TB), the cases 
with A17-A18 (extrapulmonary TB only), the cases with A19 (mil-
iary TB), the cases with A15.4 or A16.3 (mediastinal TB lymph-
adenitis only), and the cases with A15.6 or A16.5 (TB pleurisy 
only) were excluded. A total of 1,126 PTB cases remained for 
further analysis. To assess the completeness of notifications, 
laboratory data including initial chest radiographs and follow-
up chest radiographs after the initiation of anti-TB treatment as 
well as clinical symptoms at diagnosis were also examined. 
 
Proposed classification of TB
All the cases were reclassified into nine categories using clini-
cal, laboratory, or radiologic data (1, 14): ‘definite TB’ cases (cat-
egory 1, acid-fast bacilli [AFB] culture positive); ‘probable TB’ 
cases (category 2, smear positive; category 3, TB PCR positive; 
category 4, histopathologically diagnosed; category 5, broncho-
scopically positive, i.e. compatible with endobronchial tuber-
culosis; category 6, radiographically active TB on chest CT ex-
amination; category 7, active TB on initial simple chest radio-
graphs with symptoms for more than two weeks or ‘possible TB’ 
cases for more sensitive inclusion (category 8, active TB on ini-
tial simple chest radiograph other than category 7; category 9, 
radiographical improvement with anti-TB treatment). ‘Radio-
graphically active TB’ was defined as cases with multinodular 
lesions, miliary nodules, cavity or airspace consolidation. Calci-
fied or fibrotic lesions were excluded. The reports provided by 
the radiologist at each applicable hospital were used. Lastly ‘im-
provement of follow-up chest radiograph’ was defined as reduc-
tion of lesions after at least one month of anti-TB medication. 
Statistical analysis
The 95% confidence intervals of each class of the notified cases 
were estimated by calculating the ratio (p), the total number of 
cases (n) divided by the number of each case,  ± 1.96 ×√{p (1-
p)/n}. Statistical analyses were performed using the SPSS ver-
sion 12.0 (SPSS Inc, Chicago, IL, USA) and STATA Version 11.1 
(StataCorp., College Station, TX, USA). 
Ethics statement 
The study was approved by the institutional review board of 
Korean Institute of Tuberculosis (IRB No. KIT-2006-05). Written 
informed consents were exempted by the board due to the ret-
rospective nature of the study.
RESULTS
Of the 1,530 randomly selected cases, 404 cases were excluded: 
219 cases were missing the ICD-10 code at notification (cases 
lacking of clinical information or cases other than TB), 86 cases 
were A17-A18 (extrapulmonary TB only), 7 cases were A19 (mil-
iary TB), 9 cases were A15.4 or A16.3 (mediastinal TB lymphad-
enitis only), 83 cases were A15.6 or A16.5 (TB pleurisy only).
  A total of 1,126 PTB patients from private sectors was includ-
ed in the analysis as described above. The median age was 45 yr 
(range 2-96) and 60.6% of the patients were male. Baseline char-
acteristics including type of cases, type of tuberculosis, ICD-10 
code, clinical symptoms are summarized in Table 1. Six hun-
dred and thirty-two (56.1%) patients were notified as laboratory 
diagnosed TB cases (A15), and 74.3% of them were symptom-
atic with cough and sputum being the most common symp-
toms. 
  Laboratory tests for the diagnosis of PTB performed in private 
sector are listed in Table 2. Sputum AFB smear was performed 
in approximately 80% of the patients and 42.5% of the notified 
PTB cases were smear positive. Sputum M. tuberculosis culture 
was verified in approximately half of the patients (51%) and 29% Jeong I, et al.  •  Diagnostic Accuracy of Notified Pulmonary Tuberculosis
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of the total patients were M. tuberculosis culture positive. PCR 
(14.3%) or biopsy (3.6%) were performed in a relatively small 
number of PTB patients. Fifty-seven patients (5.1%) were exam-
ined bronchoscopically and 49% (28 cases) showed positive re-
sults (e.g. active caseating inflammation). Chest CT was performed 
in about a quarter of patients and a high positive result (83.5%) 
was reported. A simple chest radiograph was performed in the 
majority of the patients (71.1%) and ‘radiographically active PTB’ 
lesions were reported in 77%. The most commonly involved site 
of the lung was right upper lung field (31.7%). The left upper lung 
field was the next most commonly involved site (27.7%). A fol-
low-up radiologic examination at least one month after the ini-
tiation of anti-TB medication was assessed in 454 patients and 
77.5% showed radiologic improvement. When the utilization of 
the diagnostic modalities by private sector scale was analyzed, 
the performance rates of all the diagnostic methods including 
AFB smear and culture, TB PCR, bronchoscopy, chest radiogra-
phy and chest CT were lower in primary clinic compared to those 
of secondary and tertiary hospitals (Table 2). Definite TB, cate-
gorized as a M. tuberculosis complex culture positive case, was 
observed in 28.9% (95% CI, 26.3%-31.5%) of the total patients. 
When the diagnostic criteria of TB was extended according to 
the proposed classification, definite and probable TB combined 
was 73.2% (95% CI, 70.6%-75.8%); and definite, probable, and 
possible TB combined was 81.7% (95% CI, 79.4%-84.0%) (Table 
3). A detailed microbiological information of categories 5, 6, 7 is 
summarized in Table 4. When the analyses were limited to the 
patients who were notified as presumptive TB patients (PTB not 
confirmed bacteriologically or histologically; A16), definite case 
was observed in only one patient. Definite and probable TB cases 
were observed in 41.7% (95% CI, 37.4%-46.0%); and definite, 
probable, and possible TB cases were 60.1% (95% CI, 55.8%-
64.4%) of the total patients, respectively (Table 5).
  A total of 206 cases did not meet the criteria of the proposed 
categories 1-9. Of these, 143 cases were treated with anti-TB 
medication for less than 30 days, 21 cases for 30 to 90 days, and 
42 cases for longer than 90 days (34 patients were treated for 
longer than six months). 
DISCUSSION
In this study, definite TB cases confirmed by culture of M. tuber-
culosis complex (category 1, the current gold standard of diag-
nosis of TB) were only 28.9% (95% CI, 26.3%-31.5%) of the total 
cases. The percentage of definite cases or bacteriologically, patho-
logically or bronchoscopically probable TB cases (category 2-5) 
were 55.7% (95% CI, 52.8%-58.6%) of the total cases, and if radio-
graphically positive TB cases (category 6-7) are also included, 
the percentage of the “definite or probable TB” cases became 
73.2% of the total cases. 
  When possible cases were regarded as real TB (category 1-9), 
still the percentage of real TB was 81.7% (95% CI, 79.4%-84.0%), 
not 100%. Due to the nature of a retrospective study, the limita-
tions concerning a lack of sufficient information despite an ex-
tensive review of the medical records is encountered. The defi-
nite number of cases that were not real TB among cases not in-
cluded in Category 1-9 could not be determined. Therefore, the 
results should not be interpreted directly as ‘only 81.7% of the 
notified new PTB patients had real PTB’ or ‘approximately 20% 
Table 1. Baseline characteristics
Parameters No. of cases (%)
Number of total subjects         1,126 (%)
Age (yr), median (range) 45 (2-96)
Male sex 682 (60.6)
Province
   Seoul
   Busan
   Daegu
   Incheon
   Daejeon
   Gwangju
   Ulsan
   Gyeonggi-do
   Gangwon-do
   Chungcheongbuk-do
   Chungcheongnam-do
   Gyeongsangbuk-do
   Gyeongsangnam-do
   Jeollabuk-do
   Jeollanam-do
   Jeju-do
  
352 (31.3)
123 (10.9)
54 (4.8)
43 (3.8)
40 (3.6)
26 (2.3)
11 (1.0)
178 (15.8)
46 (4.1)
19 (1.7)
29 (2.6)
29 (2.6)
83 (7.4)
53 (4.7)
32 (2.8)
8 (0.7)
Type by previous history
   New
   Relapse
   Transfer in
   Treatment after default
   Treatment after failure
   Others
   Unknown
  
856 (76.0)
80 (7.1)
36 (3.2)
7 (0.6)
8 (0.7)
25 (2.2)
97 (8.6)
Classification by ICD-10 code
   A15 (exclusion of A15.4, A15.6) 
      A15.0
      A15.1
      A15.2
      A15.3
      A15.5
632 (56.1)
490 (77.5)
99 (15.7)
17 (2.7)
24 (3.8)
2 (0.3)
   A16 (exclusion of A16.3, A16.5) 
      A16.0
      A16.1
      A16.2
      A16.4
494 (43.9) 
262 (53.0)
171 (34.6)
60 (12.1)
1 (0.2)
Initial symptoms associated with tuberculosis
   Asymptomatic 82 (7.3)
   Symptomatic
      Cough
      Sputum
      Hemoptysis
      Chest pain
      Fatigue
      Weight loss
      Fever
      Dyspnea
      Others
837 (74.3)
638 (56.7)
462 (41)
117 (10.4)
148 (13.1)
106 (9.4)
104 (9.2)
189 (16.8)
169 (15.0)
97 (8.6)Jeong I, et al.  •  Diagnostic Accuracy of Notified Pulmonary Tuberculosis
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of the notified new PTB patients did not have TB’. However, the 
study suggests that some cases notified as PTB might not be real 
TB. In fact, 69% of 206 cases that were not included in categories 
1-9 were treated with anti-TB medication for less than one month, 
which suggests that some may be cases with other than PTB, 
such as pneumonia. So far, most reports focused on underesti-
mation of TB by the notification system and emphasized the im-
portance of notification (10, 17, 18). On the contrary, this study 
may suggests the possibility of overestimation of tuberculosis.
  It is possible that the microbiological tests are not performed 
sufficiently when physicians diagnose a case as PTB in Korea, 
which could lead to overdiagnosis. Although WHO recommends 
Table 2. The test modality and yield for diagnosis of tuberculosis that performed in private sector of Korea classified by scale of private hospital  (n = 1,126)
Diagnosis by Total No. (%) Tertiary (n = 734) Secondary (n = 148) Primary (n = 244) 
Sputum AFB smear
   Uncertain 98 (8.7) 53 (7.2%) 12 (8.1%) 33 (13.5%)
   Not done 137 (12.2) 56 (7.6%) 17 (11.5%) 64 (26.2%)
   Done
      One time
      More than two times
      Unknown times
891 (79.1)
135 (12.0)
398 (35.3)
358 (31.8)
625 (85.1%)
99 (13.5%)
298 (40.6%)
228 (31.1%)
119 (80.4%)
17 (11.5%)
49 (33.1%)
53 (35.8%)
147 (60.2%)
19 (7.8%)
51 (20.9%)
77 (31.6%)
   Positive results 479 (42.5) 352 (48.0%) 62 (41.9%) 65 (26.6%)
Sputum M. tuberculosis culture 
   Uncertain 
   Not done
   Done
   Positive results
 
203 (18.0)
349 (31.9)
574 (51.0)
326 (29.0)
 
131 (17.8%)
171 (23.3%)
432 (58.9%)
249 (33.9%)
 
23 (15.5%)
46 (31.1%)
79 (53.4%)
42 (28.4%)
 
49 (20.1%)
132 (54.1%)
63 (25.8%)
35 (14.3%)
PCR
   Uncertain or not done
   Done
   Positive results
 
965 (85.7)
161 (14.3)
87 (7.7)
 
594 (80.9%)
140 (19.1%)
79 (10.8%)
 
131 (88.5%)
17 (11.5%)
8 (5.7%)
 
240 (98.4%)
4 (1.6%)
0
Biopsy
   Unknown or not done
   Done
   Positive results
 
1,063 (94.4)
63 (5.6)
40 (3.6)
 
680 (92.6%)
54 (7.4%)
34 (4.6%)
 
145 (98.0%)
3 (2.0%)
2 (1.4%)
 
238 (97.5%)
6 (2.5%)
4 (1.6%)
Bronchoscopy
   Unknown or not done
   Done
   Positive results
 
1,069 (94.9)
57 (5.1)
28 (2.5)
 
680 (92.6%)
54 (7.4%)
27 (3.7%)
  
146 (98.6%)
2 (1.4%)
1 (0.7%)
 
243 (99.6%)
1 (0.4%)
0
Chest CT        
   Uncertain or not done 850 (75.5) 502 (68.4%) 123 (83.1%) 225 (92.2%)
   Done
      Active TB
      Indeterminate activity
      Old TB
      Other disease
      Normal chest CT
276 (24.5)
233 (84.4)
29 (10.5)
9 (3.2)
3 (1.1)
2 (0.7)
232 (31.6%)
194 (83.6%)
26 (11.2%)
9 (3.9%)
3 (1.3%)
0
25 (16.9%)
24 (96.0%)
1 (4.0%)
0
0
0
19 (7.8%)
15 (78.9%)
2 (10.5%)
0
0
2 (10.5%)
Chest radiography
   Uncertain 
   Not done
   Done
 
266 (23.6)
59 (5.2)
801 (71.1)
 
139 (18.9%)
39 (5.3%)
556 (75.7%)
 
45 (30.4%)
7 (4.7%)
96 (64.9%)
 
82 (33.6%)
13 (5.3%)
149 (61.1%)
Location 
   Right upper lung
   Right middle lung
   Right lower lung
   Left upper lung
   Left lower lung
   Multilobar involvement
 
357 (31.7)
122 (10.8)
125 (11.1)
312 (27.7)
103 (9.1)
224 (19.9)
 
247 (33.7%)
93 (12.7%)
101 (13.8%)
216 (29.4%)
76 (10.4%)
165 (18.4%)
 
41 (27.7%)
11 (7.4%)
15 (10.1%)
34 (23.0%)
12 (8.1%)
23 (15.5%)
 
69 (28.3%)
18 (7.4%)
9 (3.7%)
62 (25.4%)
15 (6.1%)
36 (14.8%)
Pattern (n = 801)
   Compatible with active pulmonary TB*
   Indeterminate activity:Consolidation without nodule
   Old TB 
   Pleural effusion without lung lesion
   Other disease
   Normal chest radiograph
 
618 (54.9)
109 (9.7)
25 (2.2)
22 (2.6)
16 (1.4)
11 (1.0)
 
425 (57.9%)
69 (9.4%)
21 (2.9%)
20 (2.7%)
13 (1.8%)
8 (1.1%)
 
78 (52.7%)
13 (8.8%)
3 (2.0%)
0
2 (1.4%)
0
 
115 (47.1%)
27 (11.1%)
1 (0.4%)
2 (0.8%)
1 (0.4%)
3 (1.2%)
Radiological improvement after anti-TB treatment
† (n = 454) 352 (31.3) 246 (33.5%) 34 (23.0%) 72 (29.5%)
*Cases with a cavity, multiple nodules, or consolidation; 
†Assessed at least one month after anti-TB treatment. AFB, acid fast bacilli; PCR, polymerase chain reaction; CT, com-
puterized tomography; TB, tuberculosis.Jeong I, et al.  •  Diagnostic Accuracy of Notified Pulmonary Tuberculosis
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that patients suspected of having TB should have appropriate 
specimens collected for smear and culture for M. tuberculosis 
(19), smear-positive patients were 42.5% among the new PTB 
cases in our study, which is lower to some degree than that of 
global epidemiology data that showed smear-positive rate of ap-
proximately 57% in 2008 (1). It may be due to the fact that spu-
tum test is less requested in Korea than in other countries in sub-
stantial number of patients with suspected TB. Sputum smear 
and culture test results for M. tuberculosis could be verified only 
in 79% and 51% of cases, respectively, in our study. It is possible 
that the physicians did not request sputum tests or have request-
ed sputum smears only without culture. According to a Korean 
study performed at a tertiary hospital, the initial sputum exami-
nations were not performed at the time of diagnosis of PTB in 
20% of patients which was similar to our results (Table 2) (20).
  The guidelines for TB management in Korea published in 2004 
recommended doctors to collect two sputum specimens for 
AFB smear and at least one for culture from cases that are sus-
pected to have PTB (suspicious findings on chest radiographs 
or suspicious symptoms of PTB) in the diagnosis of PTB (21). In 
our study, we verified sputum culture results in 51% and requests 
of two or more sputum AFB smear tests in 35.3% of total patients. 
The rates are obviously lower than those of public sectors. In 
2004 (the same year of our study), the request rate of AFB smear 
( = [total count of requested AFB smear tests] ÷ [total number 
of registered PTB cases × 2]) was 95% and that of culture in pub-
lic health care centers was 98%. 
  One of the possible explanations for the lack of adherence       
to the national guideline in the diagnosis of PTB is the capacity 
Table 3. Diagnosis of pulmonary TB by categories classified by scale of private hospitals
Category       No. Percentage (95% CI) Tertiary Secondary Primary
Total 1,126 100% 734 148 244
Definite
      Category 1. Culture positive
 
326
 
28.9% (26.3-31.5)
 
249 (33.9%)
 
42 (28.4%)
 
35 (14.3%)
Probable
   Bacteriologically 
      Category 2. Smear positive
      Category 3. TB-PCR positive
   Pathologically
      Category 4. Histologically positive
   Bronchoscopically
      Category 5. Bronchoscopically positive (endobronchial TB)
   Radiologically
      Category 6. ‘active TB’ on CT
      Category 7. ‘active TB’ on initial chest radiograph and symptom > 14 days
      one of 1-7
 
 
479
87
 
40
 
28
 
233
417
824
 
 
42.5% (39.6-45.4)
7.7% (6.1-9.3)
 
3.6% (2.5-4.7)
 
2.5% (1.6-3.4)
 
20.7% (18.3-23.1)
37.0% (34.2-39.8)
73.2% (70.6-75.8)
 
 
352 (48.0%)
79 (10.8%)
 
34 (4.6%)
 
27 (3.7%)
 
194 (26.4%)
285 (38.8%)
583 (79.4%)
 
 
62 (41.9%)
8 (5.4%)
 
2 (1.4%)
 
1 (0.6%)
 
24 (16.2%)
50 (33.8%)
106 (71.6%)
 
 
65 (26.6%)
0
 
4 (1.6%)
 
0
 
15 (6.1%)
82 (33.6%)
135 (55.3%)
Possible
      Category 8. ‘active TB’ on initial chest radiograph other than category 7
      Category 9. Improvement with anti-TB treatment on F/U chest x-ray
      one of 1-9
 
201
352
920
 
17.9% (15.7-20.1)
31.3% (28.6-34.0)
81.7% (79.4-84.0)
 
140 (19.1%)
246 (33.5%)
635 (86.5%)
 
28 (18.9%)
34 (23.0%)
120 (81.1%)
 
33 (13.5%)
72 (29.5%)
165 (67.6%)
Table 4. Smear requests and positivity of bronchoscopically and radiographically diag-
nosed pulmonary tuberculosis
Category Smear positive Culture positive
Category 5 (n = 28)     16/23 (69.6%)    13/18 (72.2%)
Category 6 (n = 233)   95/188 (50.5%)  67/127 (52.8%)
Category 7 (n = 417) 237/347 (68.3%) 165/238 (69.3%)
Table 5. Diagnosis of laboratory undiagnosed pulmonary TB (A16.0-2,4)
Category       No. Percentage (95% CI)
Total 494 100%
Definite
   Category 1. Culture positive
  
        1/151
  
0.2% (0-0.6)
Probable
   Category 2. Smear positive
   Category 3. TB-PCR positive
   Category 4. Histologically positive
   Category 5. Bronchoscopically positive
   Category 6. ‘active TB’ on CT
   Category 7. ‘active TB’ on chest radiograph AND symptom > 14 days
   one of 1-7
  
        1/241
      7/53
      2/16
      3/19
    100/119
    128/318
206
  
0.2% (0-0.6)
1.4% (0.4-2.5)
0.4% (0-1.0)
0.6% (0-1.3)
20.2% (16.7-23.8)
25.9% (22.0-29.8)
41.7% (37.4-46.0)
Possible
   Category 8. ‘active TB’ on initial chest radiograph other than category 7
   Category 9. Improvement with anti-TB treatment on F/U chest radiograph  
   one of 1-9
  
  94
131
297
  
19.0% (15.6-22.5)
26.5% (22.6-30.4)
60.1% (55.8-64.4)Jeong I, et al.  •  Diagnostic Accuracy of Notified Pulmonary Tuberculosis
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for sputum tests. Secondary and tertiary hospitals of Korea are 
equipped with laboratories where mycobacterial tests can be 
performed, while the majority of primary clinics are not. There-
fore private physicians in the primary clinics must send the spec-
imen to commercial or public health laboratories (e.g. public 
health care center or laboratories of Korean National Tubercu-
losis Association) for microbiological tests (specifically, the cul-
ture) which is cumbersome and requires a relatively longer pe-
riod for acquiring the results. Our data suggest that primary 
clinics rather than secondary or tertiary hospitals are less likely 
to perform sufficient microbiological tests (Tables 2, 3). Howev-
er, the exact percentage or number of physicians using the hos-
pital, commercial and public labs are unknown. 
  The low adherence to the national guideline in the diagnosis 
of TB in Korea calls for a continuing medical education and a 
greater role of the public health organization. In Korea, PPM-
DOTS (public-private mix for directly observed therapy, short 
course) have been introduced to large scale private sectors re-
cently, which could encourage physicians to adhere to the na-
tional guideline as public sectors. Such national services pro-
vided and organized in primary clinics may prove beneficial to 
primary physicians. If the accessibility to public laboratories 
improves, the diagnosis based on microbiology in private sec-
tors will also become more reliable.
  The lack of proper microbiological tests may lead to overdiag-
nosis of TB. In the absence of positive sputum AFB smears, most 
cases of PTB are diagnosed on the basis of clinical findings which 
depend heavily on the findings of chest radiographs (22). How-
ever, some limitations exist: 1) inter-observer variability in in-
terpretation of chest radiographs (23); 2) difficulty in differenti-
ation of pneumonia from PTB (24) since it shows clinical and 
radiological response with rifampicin (25, 26); 3) an inexperi-
enced physician in TB contributing to lower TB prevalence rate 
and lower diagnostic accuracy of chest radiographs (27-30); 4) 
Difficulty in differentiation from non-tuberculous mycobacteria 
(NTM) lung diseases which have been increasing in Korea (31). 
  In this study, the assessment of the diagnostic validity of PTB 
using chest radiograph at diagnosis and follow-up chest radio-
graph after at least one month of anti-tuberculosis treatment 
was performed. The diagnosis of TB can be strongly inferred by 
the clinical and radiographic response to anti-TB treatment (19). 
The cases with a cavity, multiple nodules or consolidation in ini-
tial chest radiograph were regarded as ‘compatible with active 
PTB (category 8)’ in our study, and comprised only 54.9% (95% 
CI, 52.0%-57.8%) (33-36). However, 77.5% of the 454 cases with 
follow-up chest radiographs showed radiographic response (cat-
egory 9). This suggests that a large number of cases whose initial 
chest radiographs revealed atypical findings of TB and showed 
improvement spontaneously or with a rifampicin-including anti-
TB regimen may be of other lung diseases such as pneumonia. 
  A variety of diagnostic modalities are utilized to diagnose TB 
in private sectors of Korea where medical resources and labora-
tory services are more advanced and easily accessible than those 
of other developing countries. The advanced diagnostic modal-
ities contribute to more accurate diagnosis of TB. For example, 
chest CT is more sensitive than chest radiography in the detec-
tion of PTB. According to a study that compared chest CT with 
chest radiograph, the radiographic diagnosis of TB was initially 
correct in only 49% of all tuberculosis cases, while CT diagnosis 
of PTB was correct in 91% (36). Because the definitive diagnosis 
still requires an isolation and identification of M. tuberculosis 
complex in a clinical specimen, invasive procedures such as 
bronchoscopy with washing or biopsy may help in the diagno-
sis of TB. In addition, use of polymerase chain reaction (PCR) 
detection of bacterial DNA is increasing recently in the diagno-
sis of TB. Although performance frequency of PCR was relative-
ly low (14.3%), half of the patients showed positive PCR results 
in the present study. 
  Some limitations exist due to the retrospective nature of the 
study as mentioned above. The missing data may affect the re-
sult. Chest radiography reports were found only in 71.1% of the 
patients, and chest radiograph was not performed in 5.2% of the 
notified PTB patients. Although the cases with an unknown sta-
tus of chest radiograph were 23.6%, the imaging was probably 
performed in most of those cases and assessed by clinicians with-
out the official reports of the radiologists. Patients who showed 
active TB in initial chest radiographs or improvement in the fol-
low-up chest radiographs were approximately 62% of the total 
cases (n = 695). Of the 247 cases in which whether chest radio-
graphs were performed or not is ‘uncertain’, 130 cases were clas-
sified into categories 1-9. Assuming that 62% of the remaining 
117 cases also meet the criteria for radiological TB, then addi-
tional 72 possible cases (6.4% of the total of 1,126 cases) may be 
added. Since the records of other diagnostic tests such as PCR, 
histology, or bronchoscopy mostly remained unknown, most of 
the tests of unknown status may have been categorized as ‘not 
performed’ examination. Although the TB data from the year 
2004 were analyzed in this study, it is difficult to conclude that it 
directly reflects the present clinical situation.
  In conclusion, in 2004, the private sectors in Korea utilized 
various laboratory tests in diagnosis of PTB and more than 70% 
of the notified PTB cases were ‘real TB’. The results may suggest 
the possibility of over-estimation of TB burden with the use of 
the notification-based TB data.
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